1. Light RW. Pleural diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
2. Light RW. Pleural effusions. Med Clin North Am 2011;95:1055-1070. PMID:
22032427.
3. Porcel JM, Light RW. Pleural effusions. Dis Mon 2013;59:29-57. PMID:
23374395.
4. Diaz-Guzman E, Budev MM. Accuracy of the physical examination in evaluating pleural effusion. Cleve Clin J Med 2008;75:297-303. PMID:
18491436.
5. Brims FJ, Davies HE, Lee YC. Respiratory chest pain: diagnosis and treatment. Med Clin North Am 2010;94:217-232. PMID:
20380952.
6. Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration 2008;75:4-13. PMID:
18185024.
7. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003;124:978-983. PMID:
12970026.
8. Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-1004. PMID:
21651642.
9. Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin Chest Med 2006;27:193-213. PMID:
16716813.
10. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009;64:139-143. PMID:
18852159.
11. Yilmaz U, Polat G, Sahin N, Soy O, Gulay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis 2005;63:17-22. PMID:
16035560.
12. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012;23:727-736. PMID:
22513394.
13. Raptopoulos V, Davis LM, Lee G, Umali C, Lew R, Irwin RS. Factors affecting the development of pneumothorax associated with thoracentesis. AJR Am J Roentgenol 1991;156:917-920. PMID:
2017951.
14. Jones PW, Moyers JP, Rogers JT, Rodriguez RM, Lee YC, Light RW. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003;123:418-423. PMID:
12576360.
15. Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011;66:658-662. PMID:
21459855.
16. Hooper C, Lee YC, Maskell N. BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii4-ii17. PMID:
20696692.
17. Romero-Candeira S, Fernandez C, Martin C, Sanchez-Paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001;110:681-686. PMID:
11403751.
18. Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012;17:721-726. PMID:
22372660.
19. Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med 2013;34:27-37. PMID:
23411054.
20. Villena V, Lopez-Encuentra A, Garcia-Lujan R, Echave-Sustaeta J, Martinez CJ. Clinical implications of appearance of pleural fluid at thoracentesis. Chest 2004;125:156-159. PMID:
14718435.
21. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-260. PMID:
12806236.
22. Putnam B, Elahi A, Bowling MR. Do we measure pleural fluid pH correctly? Curr Opin Pulm Med 2013;19:357-361. PMID:
23673451.
23. Mishra EK, Rahman NM. Factors influencing the measurement of pleural fluid pH. Curr Opin Pulm Med 2009;15:353-357. PMID:
19417673.
24. Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 2003;123:1887-1894. PMID:
12796164.
25. Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010;21:419-423. PMID:
20816597.
26. Sahn SA. Getting the most from pleural fluid analysis. Respirology 2012;17:270-277. PMID:
22059482.
27. Skouras V, Kalomenidis I. Chylothorax: diagnostic approach. Curr Opin Pulm Med 2010;16:387-393. PMID:
20410823.
28. Porcel JM, Bielsa S, Esquerda A, Ruiz-Gonzalez A, Falguera M. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012;23:447-450. PMID:
22726374.
29. Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem 2013;46:1484-1488. PMID:
23570862.
30. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Gonzalez A, Martinez-Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009;34:1383-1389. PMID:
19541708.
32. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 2008;47:1669-1674. PMID:
18827414.
33. Porcel JM. Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011;17:215-219. PMID:
21415751.
34. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126:1757-1763. PMID:
15596670.
35. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994;7:665-668. PMID:
7991525.
36. Light RW. Update on tuberculous pleural effusion. Respirology 2010;15:451-458. PMID:
20345583.
37. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-164. PMID:
3974296.
38. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361:1326-1330. PMID:
12711467.
39. Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I, Morell F. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005;127:1017-1022. PMID:
15764788.
40. Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010;38:472-477. PMID:
20219385.